Sandhill Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-259,917
Closed -$5.82M 79
2020
Q1
$5.82M Sell
259,917
-933,705
-78% -$25.6M 0.78% 35
2019
Q4
$35.2M Sell
1,193,622
-7,449
-0.6% -$202K 3.9% 7
2019
Q3
$31.9M Buy
1,201,071
+217,610
+22% +$6.53M 3.89% 5
2019
Q2
$33.2M Buy
983,461
+58,180
+6% +$1.89M 4.21% 5
2019
Q1
$29.7M Buy
925,281
+274,711
+42% +$8.45M 4.15% 6
2018
Q4
$20.5M Buy
650,570
+256,969
+65% +$8.41M 3.38% 10
2018
Q3
$13.7M Buy
+393,601
New +$13.8M 2.04% 26

Other funds holding ELAN

Sandhill Capital Partners's ELAN Position: Q2 2020 in Review

Sandhill Capital Partners sold out of Elanco Animal Health (ELAN) in Q2 2020, closing a stake of 259,917 shares — an estimated $5.82M sold.

Sandhill Capital Partners first reported a position in ELAN in Q3 2018 and held it in 7 quarters. The position peaked at $35.2M in Q4 2019. 372 funds tracked by Wall St. Rank hold ELAN as of Q2 2020.

  • Sandhill Capital Partners reported no remaining Elanco Animal Health position as of Q2 2020 after selling out during the quarter.
  • Sandhill Capital Partners sold 259,917 Elanco Animal Health shares in Q2 2020, an estimated $5.82M.
  • Sandhill Capital Partners first reported a position in Elanco Animal Health in Q3 2018 and held it in 7 quarters.
  • Sandhill Capital Partners's Elanco Animal Health position peaked at $35.2M in Q4 2019.
  • 372 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2020.

Based on Sandhill Capital Partners's 13F filing for Q2 2020, filed 13 Aug 2020.